|This Slide: #58 of 83|
Slide #58. Techne Corporation — Bionostics Holdings Limited
Techne Corporation (NASDAQ:TECH)
Bionostics Holdings Limited
Techne Corporation (NASDAQ: TECH) (Techne) announced today that it has finalized its previously announced acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics). Bionostics was acquired for approximately $104 million in cash, subject to adjustments following closing based on the final level of working capital.
Bio-Techne and its subsidiaries develop, manufacture and sell life science reagents, instruments and services for the research and clinical diagnostic markets.Co.'s segments include: Protein Sciences, which developes and manufactures purified proteins and reagent solutions, cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including Food and Drug Administration-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for Original Equipment Manufacturer.
TECH SEC Filing Email Alerts Service
Open the TECH Page at The Online Investor »
Strong Buy (3.56 out of 4)